SPONSOR
University of California, Irvine
Total Trials
7
Recruiting
7
Phases
Phase 1, Phase 2, Phase 1, Phase 4
Conditions studied: MyelofibrosisMyelofibrosis; AnemiaUric Acid StonesCancerNeoplasmsMyeloproliferative NeoplasmMPNEssential ThrombocythemiaPolycythemia VeraIntestinal Disease
University of California, Irvine is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Myelofibrosis, Myelofibrosis; Anemia, Uric Acid Stones, Cancer.
The trial portfolio spans Phase 1, Phase 2, Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of California, Irvine
How many clinical trials has University of California, Irvine sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by University of California, Irvine, of which 7 are actively recruiting participants. These trials cover conditions including Myelofibrosis, Myelofibrosis; Anemia, Uric Acid Stones. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of California, Irvine research focus on?
University of California, Irvine clinical trials span Myelofibrosis, Myelofibrosis; Anemia, Uric Acid Stones, Cancer, Neoplasms, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of California, Irvine clinical trial?
To participate in a University of California, Irvine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of California, Irvine trials with current recruitment status updated daily.
Clinical Trials by University of California, Irvine
NCT07281781 Phase 1, Phase 2
Recruiting
Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
Myelofibrosis
NCT06335537 Phase 1
Recruiting
Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers
Uric Acid Stones
NCT07073807
Recruiting
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
Cancer
NCT05123365 Phase 1, Phase 2
Recruiting
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
Myeloproliferative Neoplasm
NCT06112353 Phase 4
Recruiting
Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection
Intestinal Disease
NCT06720597
Recruiting
EndoPAT Device for Endothelial Dysfunction in ED
Erectile Dysfunction
NCT01166893
Recruiting
Ability of Modulated Imaging and Laser Speckle Imaging to Determine Burn Wound Severity and Healing Potential
Skin Burn Multiple
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology